FDA seeks more patient input

05/16/2013 | MedCityNews.com

The FDA is trying to engage more patients at earlier stages of the agency's decision-making processes, asking for patient input not only on drug approvals but also on clinical trial design, unmet medical needs, and the utility of new drugs and devices. "When it comes down to final decision, we want input on what risk patients are willing to tolerate to get the benefits," said James Valentine, program manager at the FDA Office of Health and Constituent Affairs.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA